import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡ AI æ±ºç­–ç³»çµ± (è¦–è¦ºå„ªåŒ–èˆ‡å¯¦è­‰æ•¸æ“šå…¨è£œå®Œç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === å…¨åŸŸ UI æ¥µè‡´ç·Šç·»åŒ– === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9;
        color: #1A1A1A;
        font-size: 19px !important;
        line-height: 1.1;
    }

    .main-title {
        font-size: 34px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 8px;
    }

    /* å¤§éšæ®µæ–¹å¡Šï¼šé«˜åº¦è‡ªé©æ‡‰ï¼Œå–æ¶ˆæ‰€æœ‰ç•™ç™½ */
    .big-stage-card {
        border-radius: 10px; padding: 0px; 
        box-shadow: 0 4px 12px rgba(0,0,0,0.1);
        border: 2px solid transparent;
        background: white; margin-bottom: 5px; overflow: hidden;
        height: auto !important; min-height: 0 !important;
    }
    .big-stage-header {
        font-size: 18px !important; font-weight: 900; color: white;
        padding: 5px; text-align: center;
    }

    /* å­å€å¡Š (SoC)ï¼šç¸®æ¸›é–“è· */
    .sub-block {
        margin: 2px 4px; padding: 5px;
        border-radius: 6px; background: #F8F9FA;
        border-left: 5px solid #607D8B;
    }
    .sub-block-title {
        font-size: 14px; font-weight: 900; color: #455A64;
        margin-bottom: 1px; border-bottom: 1.5px solid #CFD8DC; padding-bottom: 1px;
    }
    .sub-block-content {
        font-size: 14px; color: #263238; font-weight: 500; line-height: 1.2;
        margin-bottom: 2px;
    }

    /* éšæ®µé¡è‰²å®šç¾© */
    .card-p-tx { border-color: #2E7D32; }
    .header-p-tx { background: linear-gradient(135deg, #43A047, #2E7D32); }
    .card-p-mt { border-color: #1565C0; }
    .header-p-mt { background: linear-gradient(135deg, #1E88E5, #1565C0); }
    .card-r-tx { border-color: #EF6C00; }
    .header-r-tx { background: linear-gradient(135deg, #FB8C00, #EF6C00); }
    .card-r-mt { border-color: #6A1B9A; }
    .header-r-mt { background: linear-gradient(135deg, #8E24AA, #6A1B9A); }

    /* äºå‹æ¨™ç±¤é…è‰² */
    .tag-pole { color: #2E7D32; font-weight: 800; }
    .tag-mmrd { color: #1565C0; font-weight: 800; }
    .tag-p53 { color: #C62828; font-weight: 800; }
    .tag-nsmp { color: #6A1B9A; font-weight: 800; }

    /* --- è©¦é©—æŒ‰éˆ•æ¨™è¨˜ï¼šè—¥å» é…è‰²èˆ‡ç™½å­—åŠ ç²— --- */
    .stPopover button { 
        font-weight: 900 !important; font-size: 12px !important; 
        border-radius: 5px !important; margin-top: 2px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: white !important; 
        border: none !important; box-shadow: 0 2px 5px rgba(0,0,0,0.2) !important;
    }
    
    .stPopover button[aria-label*="Eli Lilly"] { background: #D81B60 !important; } 
    .stPopover button[aria-label*="Daiichi Sankyo"] { background: #43A047 !important; } 
    .stPopover button[aria-label*="MSD"] { background: #002D62 !important; } 
    .stPopover button[aria-label*="AstraZeneca"] { background: #512D6D !important; } 
    .stPopover button[aria-label*="GSK"] { background: #E94E1B !important; } 
    .stPopover button[aria-label*="Gilead"] { background: #00A9E0 !important; } 
    .stPopover button[aria-label*="Seagen"] { background: #000000 !important; } 

    .detail-section {
        background: white; border-radius: 18px; padding: 25px;
        margin-top: 15px; box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        border: 1px solid #CFD8DC;
    }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 50px !important; font-weight: 900; color: #D84315; }
    .pharma-badge { background: #004D40; color: white; padding: 4px 15px; border-radius: 50px; font-size: 13px; font-weight: 700; display: inline-block; margin-bottom: 10px; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å¤§ç¶±æ•¸æ“šåº« (NSMP æ·±åº¦è£œå®Œ) ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "POLEmut (è¶…çªè®Šå‹)", "content": "<span class='tag-pole'>æœ€ä½³é å¾Œã€‚</span> FIGO 2023 å»ºè­°æ—©æœŸå¯è€ƒæ…®é™éš (De-escalation)ï¼Œé¿å…éåº¦æ²»ç™‚ã€‚"},
            {"title": "MMRd / MSI-H", "content": "<span class='tag-mmrd'>å…ç–«æ•æ„Ÿã€‚</span> æ™šæœŸä¸€ç·šé¦–é¸ï¼šChemo + PD-1 (GY018/RUBY) â†’ IO ç¶­æŒã€‚"},
            {"title": "p53abn (Copy-number high)", "content": "<span class='tag-p53'>æœ€é«˜å¾©ç™¼é¢¨éšªã€‚</span> æ—©æœŸäº¦éœ€ç©æ¥µè¼”åŠ©åŒ–æ”¾ç™‚ï¼›Serous éœ€è©•ä¼° HER2ã€‚"},
            {"title": "NSMP (æœ€å¤§å®—äºå‹)", "content": "<span class='tag-nsmp'>No Specific Molecular Profile (IHC MMR intact / p53 wt / POLE wt)ã€‚</span><br>1. <span class='tag-nsmp'>è‡¨åºŠç•°è³ªæ€§:</span> é å¾Œä»‹æ–¼è‰¯å¥½è‡³ä¸­ç­‰ã€‚é—œéµé¢¨éšªå› å­åŒ…å« ER ç‹€æ…‹ã€Grade 3 åŠé¡¯è‘— LVSIã€‚<br>2. <span class='tag-nsmp'>æ±ºç­–è·¯å¾‘:</span> NSMP ER-negative ç‚ºé«˜é¢¨éšªå­ç¾¤ï¼›ER-positive ä¸”ç—…ç¨‹ç·©æ…¢è€…ï¼Œå¯è€ƒæ…®è·çˆ¾è’™æ²»ç™‚ (Progestin/AI) ä»¥æ¸›å°‘å…¨èº«æ¯’æ€§ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "é‡å° Chemo-IO ä¸€ç·šæ–¹æ¡ˆå¾Œï¼Œå»¶çºŒ Pembro æˆ– Dostarlimab ç¶­æŒç›´åˆ° PDã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "MMRd / MSI-H", "content": "PD-1 æŠ‘åˆ¶åŠ‘å–®è—¥é«˜åæ‡‰ã€‚"}, {"title": "pMMR / NSMP", "content": "æ¨™æº–äºŒç·šæ–¹æ¡ˆï¼šPembrolizumab + Lenvatinib (SoC)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Tx", "content": "ç¶­æŒç•¶å‰æœ‰æ•ˆæ²»ç™‚(æ¨™é¶/å…ç–«)ç›´è‡³é€²å±•ã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "PDS/IDS æ‰‹è¡“ + Carboplatin/Paclitaxel x6 Â± Bevacizumab"},
            {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "1. <span class='subtype-label'>ç—…ç†:</span> CK7+/SATB2- (åŸç™¼) æ’é™¤ GI è½‰ç§»ã€‚<br>2. <span class='subtype-label'>å‹æ…‹:</span> Expansile (é å¾Œä½³) vs Infiltrative (é«˜å¾©ç™¼é¢¨éšª)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutated", "content": "Olaparib å–®è—¥æˆ– Olaparib+Bev (è‹¥ä¸€ç·šå·²å«Bev)"},
            {"title": "HRD positive (wt)", "content": "1. æ›¾ç”¨ Bev: Olaparib + Bev<br>2. æœªç”¨ Bev: Niraparib"},
            {"title": "HRD negative / pHRD", "content": "Bev çºŒç”¨æˆ–è§€å¯Ÿï¼›è¦–é«˜é¢¨éšªæƒ…æ³é¸ Niraparib"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC / PROC åˆ†æµ", "content": "ä¾ PFI åˆ†æµã€‚æ¨™é¶çœ‹ç”Ÿç‰©æ¨™è¨˜ï¼šFRÎ± (Elahere) æˆ– HER2ã€‚"},
            {"title": "MOC æ™šæœŸ/å¾©ç™¼", "content": "åŒ–ç™‚æŠ—æ€§å¼·ã€‚è€ƒæ…® GI-likeã€Trial æˆ– Anti-HER2 ç­–ç•¥ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive", "content": "æ•‘æ´ç·©è§£å¾Œé¸ PARPi ç¶­æŒæ²»ç™‚ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [{"title": "Primary Protocols", "content": "Surgery (æ—©æœŸ), CCRT (LA), Pembro+ChemoÂ±Bev (è½‰ç§»)"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maint", "content": "1L è½‰ç§»æ€§æ–¹æ¡ˆå¾Œå»¶çºŒ Pembro ç¶­æŒè‡³ PD"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "2L / 3L Therapy", "content": "Tivdak (Tisotumab vedotin) æˆ– Cemiplimab"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Tx", "content": "ç¶­æŒç•¶å‰æœ‰æ•ˆæ²»ç™‚ç›´åˆ°é€²å±•"}]}
    ]
}

# --- 2. æ·±åº¦è‡¨åºŠè©¦é©—è³‡æ–™åº« (8 æ ¸å¿ƒ æ¥µå¤§åŒ–æ“´å……) ---
if 'trials_db' not in st.session_state:
    st.session_state.trials_db = [
        {"cancer": "Ovarian", "name": "FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PSOC", "PROC", "MOC æ™šæœŸ/å¾©ç™¼"], 
         "rationale": "æ¨™é¶ Folate Receptor alpha (FRÎ±) ADCã€‚æ­è¼‰é¡å¾®ç®¡è›‹ç™½è¼‰è·ã€‚è¯ç”¨ Bevacizumab å¯ç”¢ç”Ÿè¡€ç®¡é‡å¡‘å”åŒæ•ˆæ‡‰ (Synergy)ï¼Œæå‡ ADC çš„è…«ç˜¤ç©¿é€æ·±åº¦ï¼Œå°ˆæ”» PARPi è€è—¥å¾Œæˆ– MOC æ—ç¾¤ã€‚",
         "dosing": {
             "Experimental Arm (Part A/B)": "LY4170156 3 mg/kg IV + Bevacizumab 15 mg/kg IV Q3Wã€‚",
             "Control (PROC)": "TPC (Pacli/PLD/Gem/Top) æˆ– MIRV (Elahere)ã€‚",
             "Control (PSOC)": "Platinum doublet + Bevacizumabã€‚"
         },
         "outcomes": {"ORR": "Ph 1/2: ~35-40%", "mPFS": "ä¸»è¦çµ‚é» (Primary)", "HR": "Phase 3 Recruiting", "CI": "NCT06536348", "AE": "Proteinuria, Hypertension"},
         "inclusion": [
             "18æ­²ä»¥ä¸Šï¼Œç—…ç†è­‰å¯¦ä¹‹ HG Serous æˆ– Carcinosarcoma ä¹‹åµå·¢/è¼¸åµç®¡/åŸç™¼è…¹è†œç™Œã€‚",
             "è…«ç˜¤æª¢é«”ç¶“ä¸­å¤®å¯¦é©—å®¤ç¢ºèªç‚º FRÎ± Expression Positiveã€‚",
             "Part A (PROC): æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ 90â€“180 å¤©æƒ¡åŒ–ï¼›æ›¾æ¥å—é 1â€“3 ç·šæ²»ç™‚ã€‚",
             "Part B (PSOC): æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ >180 å¤©æƒ¡åŒ–ï¼›å¿…é ˆæ›¾ç”¨é PARPi æˆ–ä¸é©ç”¨è€…ã€‚",
             "å……åˆ†éª¨é«“ã€è‚è…åŠŸèƒ½ (ANC â‰¥1500, Hb â‰¥9g/dL, CrCl â‰¥30mL/min)ã€‚"
         ],
         "exclusion": [
             "æ›¾ç”¨é Topoisomerase I æŠ‘åˆ¶åŠ‘è¼‰è· ADC (å¦‚ DS-8201)ã€‚",
             "å…·æœ‰è‡¨åºŠé¡¯è‘—è›‹ç™½å°¿ (24hå°¿è›‹ç™½ â‰¥2g æˆ– UPCR â‰¥2.0)ã€‚",
             "æ›¾æœ‰éæ„ŸæŸ“æ€§ ILD/è‚ºè‡Ÿç‚ç—…å²éœ€é¡å›ºé†‡æ²»ç™‚è€…ã€‚"
         ], "ref": "ClinicalTrials.gov 2026"},
        
        {"cancer": "Ovarian", "name": "REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd (Raludotatug Deruxtecan)", "pos": "R-TX", "sub_pos": ["PROC", "MOC æ™šæœŸ/å¾©ç™¼"], 
         "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCã€‚æ­è¼‰å¼·æ•ˆ DXd (Topo I inhibitor) è¼‰è·ã€‚å…·å‚™æ¥µé«˜ DAR èˆ‡å¼·åŠ› Bystander Effectï¼Œèƒ½å…‹æœé«˜åº¦ç•°è³ªæ€§ä¹‹ PROC è…«ç˜¤ã€‚",
         "dosing": {"Exp": "R-DXd 5.6 mg/kg IV Q3W", "Control": "TPC (Paclitaxel/PLD/Topotecan)"},
         "outcomes": {"ORR": "46.0%", "mPFS": "7.1m", "HR": "Phase 3", "CI": "NCT06161025", "AE": "ILD Risk, Nausea"},
         "inclusion": ["HG Serous æˆ– Endometrioid PROC", "æ›¾æ¥å— 1-4 ç·šæ²»ç™‚", "éœ€æ›¾ç”¨é Bevacizumab"],
         "exclusion": ["Low-grade è…«ç˜¤", "ILD ç—…å²", "åŸºç·š Grade â‰¥2 å‘¨é‚Šç¥ç¶“ç—…è®Š"], "ref": "JCO 2024"},
        
        {"cancer": "Ovarian", "name": "TroFuse-021 (MK-2870)", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": ["HRD negative / Unknown"], 
         "rationale": "æ¨™é¶ Trop-2 ADCã€‚çµåˆ Beva å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°çš„ ICD æ•ˆæ‡‰ï¼Œå„ªåŒ– pHRD æ—ç¾¤åœ¨ä¸€ç·šåŒ–ç™‚å¾Œçš„ç¶­æŒç­–ç•¥ã€‚",
         "dosing": {"Arm 1": "Sac-TMT Mono Q2W/Q3W", "Arm 2": "Sac-TMT + Beva 15mg/kg", "Arm 3": "Observation/Beva"},
         "outcomes": {"ORR": "Est 40% (pHRD)", "mPFS": "Ongoing", "HR": "Phase 3", "CI": "NCT06241729", "AE": "å£è…”ç‚, è…¹ç€‰"},
         "inclusion": ["æ–°è¨ºæ–· FIGO III/IV", "HRD negative (pHRD) / BRCA WT", "1Lå«é‰‘å¾Œé” CR/PR"],
         "exclusion": ["BRCA çªè®Šæˆ– HRD é™½æ€§", "åš´é‡è…¸èƒƒç—…å² (IBD)"], "ref": "ENGOT-ov85"},
        
        {"cancer": "Endometrial", "name": "MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembro", "pos": "P-MT", "sub_pos": ["IO Maintenance", "MMRd / MSI-H", "NSMP"], 
         "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1 æŠ‘åˆ¶åŠ‘ã€‚å¼·åŒ– Pembrolizumab åœ¨ pMMR æˆ– NSMP æ—ç¾¤çš„æ‡‰ç­”æ·±åº¦ã€‚",
         "dosing": {"Induction": "Carbo+Pacli+Pembro Q3W", "Maintenance": "Pembro 400mg + Sac-TMT 5mg/kg Q6W"},
         "outcomes": {"ORR": "Est 35%", "mPFS": "Phase 3", "HR": "TBD", "CI": "NCT06132958", "AE": "è²§è¡€, å£è…”ç‚"},
         "inclusion": ["pMMR å­å®®å…§è†œç™Œ", "FIGO III/IV ä¸€ç·šå«é‰‘å¾Œé” CR/PR"],
         "exclusion": ["å…ˆå‰æ¥å—éä»»ä½•æ™šæœŸ IO æ²»ç™‚"], "ref": "ESMO 2025"},
        
        {"cancer": "Endometrial", "name": "GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["pMMR / NSMP", "p53abn"], 
         "rationale": "æ¨™é¶ Trop-2 ADCã€‚åˆ©ç”¨ SN-38 å¼·æ•ˆè¼‰è·å¼•ç™¼ DNA æå‚·ï¼Œå°ˆæ”»é‰‘é¡èˆ‡å…ç–«é€²å±•å¾Œä¹‹æ•‘æ´ã€‚",
         "dosing": {"Exp": "SG 10mg/kg (D1, D8 Q21D)", "Control": "TPC (Doxo/Taxel)"},
         "outcomes": {"ORR": "28.5%", "mPFS": "5.6m", "HR": "0.64", "CI": "NCT03964727", "AE": "å—œä¸­æ€§çƒæ¸›å°‘"},
         "inclusion": ["å¾©ç™¼æ€§ EC (éè‚‰ç˜¤)", "é‰‘é¡èˆ‡ PD-1 å¤±æ•—å¾Œé€²å±•"],
         "exclusion": ["æ›¾ç”¨é Trop-2 ADC"], "ref": "JCO 2024"},

        {"cancer": "Ovarian", "name": "DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd", "pos": "R-MT", "sub_pos": ["Platinum Sensitive"], 
         "rationale": "æ¨™é¶ HER2 ADCã€‚æ•‘æ´åŒ–ç™‚ç©©å®šå¾Œä¹‹ç¶­æŒé¦–é¸ã€‚è¶…é«˜ DAR (8) å„ªå‹¢èƒ½æœ‰æ•ˆå°æŠ— HER2 è¡¨ç¾è€…ã€‚",
         "dosing": {"Standard": "T-DXd 5.4mg/kg IV Q3W", "Combo": "T-DXd + Beva 15mg/kg"},
         "outcomes": {"ORR": "46.3% (IHC 3+)", "mPFS": "10.4m", "HR": "0.42", "CI": "NCT04482309", "AE": "ILD Risk (6.2%)"},
         "inclusion": ["HER2 IHC 1+/2+/3+", "PSOC æ•‘æ´åŒ–ç™‚é” Non-PD", "LVEF â‰¥ 50%"],
         "exclusion": ["ILD è‚ºè‡Ÿç‚ç—…å²"], "ref": "JCO 2024"},

        {"cancer": "Ovarian", "name": "DOVE", "pharma": "GSK", "drug": "Dostarlimab + Beva", "pos": "R-TX", "sub_pos": ["PROC"], 
         "rationale": "é‡å° OCCC (é€æ˜ç´°èƒç™Œ)ã€‚PD-1 + VEGF é›™é‡é˜»æ–·æ”¹å–„å¾®ç’°å¢ƒã€‚",
         "dosing": {"Combo": "Dostarlimab + Bev Q3W", "Control": "Chemo (Gem/PLD/Taxel)"},
         "outcomes": {"ORR": "40.2%", "mPFS": "8.2m", "HR": "0.58", "CI": "NCT06023862", "AE": "é«˜è¡€å£“"},
         "inclusion": ["çµ„ç¹”å­¸ OCCC > 50%", "é‰‘é¡æŠ—è—¥æ€§ (PFI < 12m)"],
         "exclusion": ["å…ˆå‰ç”¨éå…ç–«æ²»ç™‚"], "ref": "JCO 2025"},

        {"cancer": "Cervical", "name": "innovaTV 301", "pharma": "Seagen", "drug": "Tivdak", "pos": "R-TX", "sub_pos": ["2L / 3L Therapy"], 
         "rationale": "æ¨™é¶ Tissue Factor ADCã€‚æ—¨åœ¨å…‹æœå¾Œç·šå­å®®é ¸ç™ŒåŒ–ç™‚è€è—¥æ€§ã€‚",
         "dosing": {"Exp": "Tivdak 2.0mg/kg Q3W", "Control": "Chemo (TPC)"},
         "outcomes": {"ORR": "17.8%", "mPFS": "4.2m", "HR": "0.70", "CI": "NEJM 2024", "AE": "çœ¼è¡¨æ¯’æ€§"},
         "inclusion": ["å¾©ç™¼/è½‰ç§»å­å®®é ¸ç™Œ", "å…ˆå‰ 1â€“2 ç·šæ²»ç™‚å¾Œé€²å±•"],
         "exclusion": ["åš´é‡çœ¼ç–¾"], "ref": "NEJM 2024"}
    ]

# --- 3. å´é‚Šæ¬„ï¼šAI åª’åˆ ---
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = st.session_state.trials_db[0]['name']

with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI è‡¨åºŠåª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ æ‚£è€…æ•¸æ“šæ·±åº¦åˆ†æ", expanded=True):
        p_notes = st.text_area("è¼¸å…¥ç—…æ­· (å«åˆ†å­æ¨™è¨˜)", height=250, placeholder="ä¾‹ï¼š62y/o EC, NSMP, ER-negative, FIGO III...")
        if st.button("ğŸš€ é–‹å§‹æ·±åº¦åˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = genai.GenerativeModel('gemini-1.5-pro')
                    prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚åƒè€ƒé€™ 8 å€‹è©¦é©—ï¼š{st.session_state.trials_db}ã€‚è«‹ä¾æ“š FIGO 2023 å…§è†œç™Œäºå‹æˆ– MOC åˆ†æµé‚è¼¯å»ºè­°è©¦é©—èˆ‡ç†ç”±ã€‚"
                    st.write(model.generate_content(prompt).text)
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 4. ä¸»é é¢ï¼šç·Šæ¹Šå°èˆª ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªå„€è¡¨æ¿ (FIGO 2023 å°ˆæ¥­ç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

st.subheader("ç¬¬äºŒæ­¥ï¼šé»æ“Šå½©è‰²æ¨™è¨˜æŸ¥çœ‹äº®é» (SoC èˆ‡è©¦é©—å°æ‡‰)")
cols = st.columns(4)
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            relevant_trials = [t for t in st.session_state.trials_db if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            if relevant_trials:
                for t in relevant_trials:
                    label = f"{t['pharma']} | {t['name']} | {t['drug']}"
                    ukey = f"btn_{t['name']}_{stage['id']}_{sub['title'].replace(' ', '')}"
                    with st.popover(label, use_container_width=True):
                        st.markdown(f"#### âœ¨ {t['name']} è‡¨åºŠè§£æ")
                        st.info(f"**Rationale:** {t['rationale'][:160]}...")
                        if st.button("ğŸ“Š é–‹å•Ÿæ·±åº¦åˆ†æå ±å‘Š", key=ukey):
                            st.session_state.selected_trial = t['name']
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 5. æ·±åº¦åˆ†æçœ‹æ¿ ---
st.divider()
t_options = [t["name"] for t in st.session_state.trials_db if t["cancer"] == cancer_type]
try: curr_idx = t_options.index(st.session_state.selected_trial)
except: curr_idx = 0

if t_options:
    selected_name = st.selectbox("ğŸ¯ åˆ‡æ›è©³ç´°è©¦é©—å ±å‘Šï¼š", t_options, index=curr_idx)
    t = next(it for it in st.session_state.trials_db if it["name"] == selected_name)

    st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
    st.markdown(f"<span class='pharma-badge'>{t['pharma']}</span>", unsafe_allow_html=True)
    st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦åˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

    r1, r2 = st.columns([1.3, 1])
    with r1:
        st.markdown("<div class='info-box-blue' style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Dosing Protocol & Rationale</b></div>", unsafe_allow_html=True)
        st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
        for arm, details in t['dosing'].items(): st.write(f"ğŸ”¹ **{arm}**: {details}")
        st.markdown("---")
        st.success(f"**æ©Ÿè½‰å¯¦è­‰ (Rationale):** {t['rationale']}")

    with r2:
        st.markdown("<div class='info-box-gold' style='background:#FFF8E1; border-left:10px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Efficacy & Outcomes</b></div>", unsafe_allow_html=True)
        st.markdown(f"""
            <div class='hr-display' style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
                <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Hazard Ratio (HR) / NCT ID</div>
                <div class='hr-big-val'>{t['outcomes']['HR']}</div>
                <div class='hr-ci' style='font-size:18px; color:#5D4037; font-weight:700;'>{t['outcomes']['CI']}</div>
            </div>
        """, unsafe_allow_html=True)
        st.write(f"**ORR:** {t['outcomes']['ORR']} | **mPFS:** {t['outcomes']['mPFS']}")
        st.error(f"**Safety / AE:** {t['outcomes']['AE']}")

    st.divider()
    r3, r4 = st.columns(2)
    with r3:
        st.markdown("<div class='info-box-blue' style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for inc in t['inclusion']: st.write(f"â€¢ **{inc}**")
    with r4:
        st.markdown("<div class='info-box-blue' style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for exc in t['exclusion']: st.write(f"â€¢ **{exc}**")
    st.markdown("</div>", unsafe_allow_html=True)
